Violich Capital Management, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 871 filers reported holding NOVARTIS A G in Q3 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.

Quarter-by-quarter ownership
Violich Capital Management, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$433
+0.9%
4,2500.0%0.07%
+7.2%
Q2 2023$429
+9.7%
4,2500.0%0.07%
+3.0%
Q1 2023$391
+1.3%
4,2500.0%0.07%
-2.9%
Q4 2022$386
-99.9%
4,2500.0%0.07%
+13.1%
Q3 2022$323,000
-17.8%
4,250
-8.6%
0.06%
-11.6%
Q2 2022$393,000
-3.7%
4,6500.0%0.07%
+15.0%
Q1 2022$408,000
-1.7%
4,650
-1.9%
0.06%0.0%
Q4 2021$415,000
+7.0%
4,7400.0%0.06%
-3.2%
Q3 2021$388,000
+8.1%
4,740
+20.3%
0.06%
+3.3%
Q2 2021$359,000
-11.4%
3,940
-16.9%
0.06%
-17.8%
Q1 2021$405,000
-9.6%
4,7400.0%0.07%
-16.1%
Q4 2020$448,000
+8.7%
4,7400.0%0.09%0.0%
Q3 2020$412,000
-40.3%
4,740
-40.0%
0.09%
-42.4%
Q2 2020$690,000
+8.2%
7,896
+2.0%
0.15%
-11.7%
Q1 2020$638,000
-9.4%
7,740
+4.0%
0.17%
+11.0%
Q4 2019$704,000
+8.8%
7,4400.0%0.15%
-1.3%
Q3 2019$647,000
-4.7%
7,4400.0%0.16%
-6.6%
Q2 2019$679,000
-5.0%
7,4400.0%0.17%
-7.7%
Q1 2019$715,000
+12.1%
7,4400.0%0.18%0.0%
Q4 2018$638,000
+3.1%
7,440
+3.5%
0.18%
+28.4%
Q3 2018$619,000
+7.7%
7,190
-5.5%
0.14%
-2.8%
Q2 2018$575,000
-7.7%
7,610
-1.2%
0.14%
-13.2%
Q1 2018$623,000
-3.6%
7,7000.0%0.17%
+1.8%
Q4 2017$646,000
-2.3%
7,7000.0%0.16%
-8.9%
Q3 2017$661,000
+1.5%
7,700
-1.3%
0.18%
-5.3%
Q2 2017$651,000
+12.4%
7,8000.0%0.19%
+8.6%
Q1 2017$579,000
-3.7%
7,800
-2.5%
0.18%
-5.4%
Q4 2016$601,000
-4.9%
8,0030.0%0.18%
-16.3%
Q3 2016$632,000
-4.2%
8,0030.0%0.22%
+6.2%
Q2 2016$660,000
+14.8%
8,003
+0.8%
0.21%
+12.4%
Q1 2016$575,000
-10.9%
7,943
+6.0%
0.18%
-13.6%
Q4 2015$645,000
-7.6%
7,493
-1.3%
0.21%
-12.3%
Q3 2015$698,000
-6.6%
7,5930.0%0.24%0.0%
Q2 2015$747,000
-0.3%
7,5930.0%0.24%
+0.4%
Q1 2015$749,000
+6.4%
7,5930.0%0.24%
+8.5%
Q4 2014$704,000
-5.2%
7,593
-3.8%
0.22%
-7.4%
Q3 2014$743,000
-27.3%
7,893
-30.1%
0.24%
-29.2%
Q2 2014$1,022,000
+2.8%
11,291
-3.4%
0.34%
-1.2%
Q1 2014$994,000
+4.2%
11,691
-1.5%
0.35%
+1.2%
Q4 2013$954,000
+4.7%
11,8700.0%0.34%
-3.7%
Q3 2013$911,000
+7.7%
11,870
-0.8%
0.36%
+3.5%
Q2 2013$846,00011,9700.34%
Other shareholders
NOVARTIS A G shareholders Q3 2014
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders